Abstract

The development of convolutional neural networks has achieved impressive advances of machine learning in recent years, leading to an increasing use of artificial intelligence (AI) in the field of gastrointestinal (GI) diseases. AI networks have been trained to differentiate benign from malignant lesions, analyze endoscopic and radiological GI images, and assess histological diagnoses, obtaining excellent results and high overall diagnostic accuracy. Nevertheless, there data are lacking on side effects of AI in the gastroenterology field, and high-quality studies comparing the performance of AI networks to health care professionals are still limited. Thus, large, controlled trials in real-time clinical settings are warranted to assess the role of AI in daily clinical practice. This narrative review gives an overview of some of the most relevant potential applications of AI for gastrointestinal diseases, highlighting advantages and main limitations and providing considerations for future development.

Highlights

  • Machine learning has evolved in recent years due to the usage of convolutional neural networks (CNN), the improvement of the training of such networks that build the basis of artificial intelligence (AI), the development of powerful computers with advanced graphics processing, and their increasing use in many diagnostic fields

  • AI has been applied in a wide range of gastrointestinal diseases, high-quality studies that compare the performance of AI networks to human health care professionals are lacking, especially studies with prospective design and that are conducted in real-time clinical settings

  • The integrated area under the curve values for recurrence-free survival (RFS) prediction were 0.616, 0.714, and 0.719 in clinical, radiomic, and the clinical and radiomic merged models, respectively

Read more

Summary

Introduction

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. AI has been applied in a wide range of gastrointestinal diseases, high-quality studies that compare the performance of AI networks to human health care professionals are lacking, especially studies with prospective design and that are conducted in real-time clinical settings. This narrative review will give an overview of some of the most relevant potential applications of AI for both upper and lower gastrointestinal diseases (Table 1), highlighting advantages and main limitations and providing considerations for future development

Key Points
Esophagus
AI and Helicobacter Pylori Infection
AI and Gastric Precancerous Lesions and Gastric Cancer
Inflammatory Bowel Disease
Polyp Detection and Colorectal Cancer
Discussion and Conclusions
Findings
Methods
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.